Can Fite Biopharma Ltd Financial Flexibility Index
Can Fite Biopharma Ltd financial flexibility index. Can Fite Biopharma Ltd (CANF) has a Financial Flexibility Index of -0.67x as of June 2025. Free cash flow of ILA-2.38 Million (operating CF ILA-2.38 Million minus capex ILA500.00) represents -1% of total liabilities (ILA3.54 Million). See Can Fite Biopharma Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Can Fite Biopharma Ltd (2010–2025)
Financial flexibility index of Can Fite Biopharma Ltd from 2010 to 2025. Historical Financial Flexibility Index trend for Can Fite Biopharma Ltd across 16 annual periods. Explore Can Fite Biopharma Ltd (CANF) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Can Fite Biopharma Ltd Financial Flexibility Index by Year (2010–2025)
Can Fite Biopharma Ltd financial flexibility index by year from 2010 to 2025. Year-by-year free cash flow to debt coverage for Can Fite Biopharma Ltd. For the full cash flow conversion analysis, see CANF operating cash flow.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.47x | ILA-9.68 Million | ILA-9.69 Million | ILA3.92 Million | ▼ -19.2% |
| 2024 | -2.07x | ILA-7.63 Million | ILA-7.64 Million | ILA3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | ILA-8.44 Million | ILA-8.44 Million | ILA3.75 Million | ▼ -0.4% |
| 2022 | -2.24x | ILA-10.79 Million | ILA-10.80 Million | ILA4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | ILA-9.85 Million | ILA-9.86 Million | ILA5.87 Million | ▲ +51.9% |
| 2020 | -3.49x | ILA-12.04 Million | ILA-12.06 Million | ILA3.45 Million | ▼ -84.7% |
| 2019 | -1.89x | ILA-10.83 Million | ILA-10.83 Million | ILA5.73 Million | ▼ -126.3% |
| 2018 | -0.83x | ILA-4.12 Million | ILA-4.16 Million | ILA4.94 Million | ▲ +58.1% |
| 2017 | -1.99x | ILA-9.52 Million | ILA-9.52 Million | ILA4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | ILA-8.92 Million | ILA-8.93 Million | ILA6.29 Million | ▼ -120.1% |
| 2015 | -0.64x | ILA-4.61 Million | ILA-4.65 Million | ILA7.16 Million | ▲ +70.7% |
| 2014 | -2.20x | ILA-7.32 Million | ILA-7.33 Million | ILA3.33 Million | ▲ +44.5% |
| 2013 | -3.96x | ILA-8.62 Million | ILA-8.63 Million | ILA2.18 Million | ▼ -113.6% |
| 2012 | -1.85x | ILA-4.34 Million | ILA-4.35 Million | ILA2.34 Million | ▲ +45.4% |
| 2011 | -3.40x | ILA-5.47 Million | ILA-5.50 Million | ILA1.61 Million | ▼ -413.1% |
| 2010 | -0.66x | ILA-3.62 Million | ILA-3.65 Million | ILA5.47 Million | — |